In view of the pluripotent role of TLR9 in DLBCL, especially of the ABC/non-germinal center B-cell (GCB) type, we investigated its potential as a prognostic marker in a population-based cohort of patients with good- and poor-prognosis DLBCL. This evidence concerns the gene TLR9 and diffuse large B-cell lymphoma.